Suppr超能文献

系统评价:心理干预对肠易激综合征治疗的安慰剂效应

Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome.

作者信息

Flik Carla E, Bakker Laura, Laan Wijnand, van Rood Yanda R, Smout André J P M, de Wit Niek J

机构信息

Carla E Flik, Laura Bakker, Wijnand Laan, Niek J de Wit, Department of General Practice, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, 3508GA Utrecht, The Netherlands.

出版信息

World J Gastroenterol. 2017 Mar 28;23(12):2223-2233. doi: 10.3748/wjg.v23.i12.2223.

Abstract

AIM

To determine the placebo response rate associated with different types of placebo interventions used in psychological intervention studies for irritable bowel syndrome.

METHODS

Randomized controlled trials comparing psychological interventions (stress management/relaxation therapy (cognitive) behavioral therapy, short-term psychodynamic therapy, and hypnotherapy) for the treatment of adult patients with irritable bowel syndrome (IBS) diagnosed with the Manning or Rome criteria with an adequate placebo control treatment and reporting data on IBS symptom severity were identified by searching PubMed, Embase, the Cochrane Library, CINAHL and PsycINFO databases. Full-text articles that were written in English and published between 1966 and February 2016 in peer-reviewed journals were selected for the present review. Placebo interventions were considered to be adequate if the number of sessions and the amount of time spent with the therapist were the same as in the active treatment. The placebo response rate (PRR) was computed for IBS symptom severity (primary outcome measure) as well as for anxiety, depression and quality of life (secondary outcome measures).

RESULTS

Six studies, with a total of 555 patients met the inclusion criteria. Four studies used an educational intervention, whereas two studies used a form of supportive therapy as the placebo intervention. The PRR for IBS symptom severity ranged from 25% to 59%, with a pooled mean of 41.4%. The relative PRR for the secondary outcome measures ranged from 0% to 267% for anxiety, 6% to 52% for depression 20% to 125% for quality of life. The PRR associated with pharmacological treatments, treatment with dietary bran and complementary medicine ranged from 37.5% to 47%. Contrary to our expectations, the PRR in studies on psychological interventions was comparable to that in studies on pharmacological, dietary and alternative medical interventions.

CONCLUSION

The PRR is probably determined to a larger extent by patient-related factors, such as expectations and desire for the treatment to be effective, than the content of the placebo intervention.

摘要

目的

确定在肠易激综合征心理干预研究中使用的不同类型安慰剂干预措施所对应的安慰剂反应率。

方法

通过检索PubMed、Embase、Cochrane图书馆、CINAHL和PsycINFO数据库,识别出比较心理干预措施(压力管理/放松疗法、认知行为疗法、短期心理动力疗法和催眠疗法)与充分的安慰剂对照治疗对符合曼宁或罗马标准诊断的成年肠易激综合征(IBS)患者进行治疗并报告IBS症状严重程度数据的随机对照试验。选择1966年至2016年2月间发表在同行评审期刊上的英文全文文章进行本综述。如果安慰剂干预的疗程数和与治疗师相处的时间与积极治疗相同,则认为该安慰剂干预是充分的。计算IBS症状严重程度(主要结局指标)以及焦虑、抑郁和生活质量(次要结局指标)的安慰剂反应率(PRR)。

结果

六项研究共555例患者符合纳入标准。四项研究使用教育干预,而两项研究使用某种形式的支持性疗法作为安慰剂干预。IBS症状严重程度的PRR范围为25%至59%,合并均值为41.4%。次要结局指标的相对PRR范围为:焦虑为0%至267%,抑郁为6%至52%,生活质量为20%至125%。与药物治疗、膳食纤维治疗和补充医学相关的PRR范围为37.5%至47%。与我们的预期相反,心理干预研究中的PRR与药物、饮食和替代医学干预研究中的PRR相当。

结论

安慰剂反应率可能在很大程度上由患者相关因素决定,例如对治疗有效性的期望和渴望,而非安慰剂干预的内容。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a029/5374135/d6ac111e1b6f/WJG-23-2223-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验